Login / Signup

Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.

Nicol G M OonkL D A DorresteijnA D van den BergJ van der PalenK L L MovigH W NijmeijerM E van KesterenH Koffijberg
Published in: European journal of clinical pharmacology (2022)
Netherlands Trial Register, NL4360. Registered 17 March 2014.
Keyphrases
  • healthcare
  • palliative care
  • study protocol
  • phase iii
  • clinical trial
  • quality improvement
  • phase ii
  • adverse drug
  • randomized controlled trial
  • open label
  • drug induced